Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
none assigned
|
| gptkbp:CASNumber |
1627707-87-7
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Incyte_Corporation
|
| https://www.w3.org/2000/01/rdf-schema#label |
INCB50465
|
| gptkbp:intendedUse |
pain management
|
| gptkbp:mechanismOfAction |
selective CB2 receptor agonist
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:target |
gptkb:cannabinoid_receptor_type_2_(CB2)
|
| gptkbp:bfsParent |
gptkb:parsaclisib
|
| gptkbp:bfsLayer |
6
|